BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 7912494)

  • 1. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
    Hal DG; Stoica G
    Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
    Mangues R; Kahn JM; Seidman I; Pellicer A
    Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
    Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
    Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
    Kern JA; Slebos RJ; Top B; Rodenhuis S; Lager D; Robinson RA; Weiner D; Schwartz DA
    J Clin Invest; 1994 Feb; 93(2):516-20. PubMed ID: 7906694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
    Ogawa K; Tokusashi Y; Fukuda I
    Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ras gene analysis in mammary tumors of dogs by means of PCR-SSCP and direct genomic analysis].
    Castagnaro M
    Ann Ist Super Sanita; 1995; 31(3):337-41. PubMed ID: 8712577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
    Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
    Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
    Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
    Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
    Zhuang SM; Wiseman RW; Söderkvist P
    Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
    Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
    Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oncogene neu in spontaneous and induced rat schwannomas: a study using polymerase chain reaction].
    Perantoni AO; Buzard GS; Turusov VS; Raĭs DM
    Arkh Patol; 1995; 57(5):38-42. PubMed ID: 8579494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
    McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
    Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
    Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
    Cancer Res; 1992 Aug; 52(15):4102-5. PubMed ID: 1353410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of oncogenes from rat mammary tumors by a highly efficient retrovirus expression cloning system.
    Tsukamoto T; Huang T; Guzman RC; Chen X; Pascual RV; Kitamura T; Nandi S
    Biochem Biophys Res Commun; 1999 Nov; 265(1):7-12. PubMed ID: 10548482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
    Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.